Skip to menu Skip to content Skip to footer
Professor Gabrielle Belz
Professor

Gabrielle Belz

Email: 

Overview

Background

Gabrielle Belz originally trained in veterinary medicine and surgery and received her PhD in understanding the organisation of lymphatics and lymphoid tissues at The University of Queensland. After a short stint in Canada to work on B cells, she moved to St Jude Children’s Research Hospital to work with Peter Doherty supported by an NHMRC CJ Martin Fellowship. Here she established a number of systems that now allow tracking of virus-specific T cells and established the paradigm changing notion that CD4 T cell help was required for generating antiviral responses. She returned to The Walter and Eliza Hall Institute of Medical Research and uncovered the identity of the key dendritic cells necessary for initiating antiviral infections. Subsequently she was awarded the Burnet Prize and NHMRC Elizabeth Blackburn Fellowship. Her research contributions have been recognized by a number of awards including a Wellcome Trust Overseas Fellowship, HHMI international fellowship, ARC Future fellowship, Doctor of Veterinary Science, the Gottschalk Medal (Australian Academy of Science) and in 2024 an ARC Laureate Fellowship. Her laboratory focuses on deciphering the key cellular and transcriptional signals of protective immunity particularly by T cells and in understanding how innate immune cells develop and make novel contributions to mucosal immune defence.

Availability

Professor Gabrielle Belz is:
Available for supervision

Qualifications

  • Bachelor of Veterinary Biology, The University of Queensland
  • Bachelor (Honours) of Veterinary Science, The University of Queensland
  • Doctor of Philosophy, The University of Queensland
  • Doctoral Diploma, The University of Queensland

Research impacts

Overall goals:

Our work aims to understand how the immune system responds to infections including viruses, bacteria and parasites.

We are elucidating how different types of immune cells develop, and what factors influences their decision to become one type of immune cell or another.

Understanding how the body deals with pathogens will give clues about how to enhance protective immunity. Our goal is to discover new therapies that boost our immune system to protect against infection.

Research interests:

Cell differentiation is the process by which cells develop and mature. In this process, cells become more specialised and acquire potent effector functions that allow them to eliminate infectious organisms. There is an urgent need to develop new therapies that focus on augmenting host immunity.

Our research focuses on:

  • Elucidating the mechanisms responsible for the generation of protective immunity in response to lung and gastrointestinal pathogens
  • How protective immunity breaks down in chronic overwhelming infections
  • Identifying factors that can promote host immune responses and potent long-lived protective immunological memory.

We have developed and use a number of in vivo models of infectious diseases including:

  • Influenza
  • Herpes virus
  • Lymphocytic choriomeningitis virus (LCMV)

These models provide us with an unprecedented opportunity to examine the mechanisms that these pathogens employ to infect hosts and elicit immune protection or to subvert the host responses. Using a variety of approaches including multiparameter flow cytometry, systems biology and global gene expression profiling we aim to define cellular and transcriptional pathways in normal memory T cell differentiation, innate immune cell subsets and immune failure.

Works

Search Professor Gabrielle Belz’s works on UQ eSpace

294 works between 1981 and 2025

121 - 140 of 294 works

2016

Journal Article

The evolution of innate lymphoid cells

Vivier, Eric, Van De Pavert, Serge A., Cooper, Max D. and Belz, Gabrielle T. (2016). The evolution of innate lymphoid cells. Nature Immunology, 17 (7), 790-794. doi: 10.1038/ni.3459

The evolution of innate lymphoid cells

2016

Journal Article

Type I interferons direct gammaherpesvirus host colonization

Tan, Cindy S. E., Lawler, Clara, May, Janet S., Belz, Gabrielle T. and Stevenson, Philip G. (2016). Type I interferons direct gammaherpesvirus host colonization. PLoS Pathogens, 12 (5) e1005654, e1005654. doi: 10.1371/journal.ppat.1005654

Type I interferons direct gammaherpesvirus host colonization

2016

Journal Article

ILC2s masquerade as ILC1s to drive chronic disease

Belz, Gabrielle T. (2016). ILC2s masquerade as ILC1s to drive chronic disease. Nature Immunology, 17 (6), 611-612. doi: 10.1038/ni.3467

ILC2s masquerade as ILC1s to drive chronic disease

2016

Journal Article

Transforming growth factor-β and Notch ligands act as opposing environmental cues in regulating the plasticity of type 3 innate lymphoid cells

Viant, Charlotte, Rankin, Lucille C., Girard-Madoux, Mathilde J. H., Seillet, Cyril, Shi, Wei, Smyth, Mark J., Bartholin, Laurent, Walzer, Thierry, Huntington, Nicholas D., Vivier, Eric and Belz, Gabrielle T. (2016). Transforming growth factor-β and Notch ligands act as opposing environmental cues in regulating the plasticity of type 3 innate lymphoid cells. Science Signaling, 9 (426) ra46, ra46-ra46. doi: 10.1126/scisignal.aaf2176

Transforming growth factor-β and Notch ligands act as opposing environmental cues in regulating the plasticity of type 3 innate lymphoid cells

2016

Journal Article

Dynamic changes in Id3 and E-protein activity orchestrate germinal center and plasma cell development

Gloury, Renee, Zotos, Dimitra, Zuidscherwoude, Malou, Masson, Frederick, Liao, Yang, Hasbold, Jhaguaral, Corcoran, Lynn M., Hodgkin, Phil D., Belz, Gabrielle T., Shi, Wei, Nutt, Stephen L., Tarlinton, David M. and Kallies, Axel (2016). Dynamic changes in Id3 and E-protein activity orchestrate germinal center and plasma cell development. Journal of Experimental Medicine, 213 (6), 1095-1111. doi: 10.1084/jem.20152003

Dynamic changes in Id3 and E-protein activity orchestrate germinal center and plasma cell development

2016

Journal Article

RUNX2 mediates plasmacytoid dendritic cell egress from the bone marrow and controls viral immunity

Chopin, Michaël, Preston, Simon P., Lun, Aaron T.L., Tellier, Julie, Smyth, Gordon K., Pellegrini, Marc, Belz, Gabrielle T., Corcoran, Lynn M., Visvader, Jane E., Wu, Li and Nutt, Stephen L. (2016). RUNX2 mediates plasmacytoid dendritic cell egress from the bone marrow and controls viral immunity. Cell Reports, 15 (4), 866-878. doi: 10.1016/j.celrep.2016.03.066

RUNX2 mediates plasmacytoid dendritic cell egress from the bone marrow and controls viral immunity

2016

Journal Article

Hobit and Blimp1 instruct a universal transcriptional program of tissue residency in lymphocytes

Mackay, Laura K., Minnich, Martina, Kragten, Natasja A. M., Liao, Yang, Nota, Benjamin, Seillet, Cyril, Zaid, Ali, Man, Kevin, Preston, Simon, Freestone, David, Braun, Asolina, Wynne-Jones, Erica, Behr, Felix M., Stark, Regina, Pellicci, Daniel G., Godfrey, Dale I., Belz, Gabrielle T., Pellegrini, Marc, Gebhardt, Thomas, Busslinger, Meinrad, Shi, Wei, Carbone, Francis R., Van Lier, René A.W., Kallies, Axel and Van Gisbergen, Klaas P. J. M. (2016). Hobit and Blimp1 instruct a universal transcriptional program of tissue residency in lymphocytes. Science, 352 (6284), 459-463. doi: 10.1126/science.aad2035

Hobit and Blimp1 instruct a universal transcriptional program of tissue residency in lymphocytes

2016

Journal Article

A molecular threshold for effector CD8+ T cell differentiation controlled by transcription factors Blimp-1 and T-bet

Xin, Annie, Masson, Frederick, Liao, Yang, Preston, Simon, Guan, Tianxia, Gloury, Renee, Olshansky, Moshe, Lin, Jian-Xin, Li, Peng, Speed, Terence P., Smyth, Gordon K., Ernst, Matthias, Leonard, Warren J., Pellegrini, Marc, Kaech, Susan M., Nutt, Stephen L., Shi, Wei, Belz, Gabrielle T. and Kallies, Axel (2016). A molecular threshold for effector CD8+ T cell differentiation controlled by transcription factors Blimp-1 and T-bet. Nature Immunology, 17 (4), 422-432. doi: 10.1038/ni.3410

A molecular threshold for effector CD8+ T cell differentiation controlled by transcription factors Blimp-1 and T-bet

2016

Journal Article

Lethal giant larvae-1 deficiency enhances the CD8+ effector T-cell response to antigen challenge in vivo

Ramsbottom, Kelly M., Sacirbegovic, Faruk, Hawkins, Edwin D., Kallies, Axel, Belz, Gabrielle T., Van Ham, Vanessa, Haynes, Nicole M., Durrant, Michael J., Humbert, Patrick O., Russell, Sarah M. and Oliaro, Jane (2016). Lethal giant larvae-1 deficiency enhances the CD8+ effector T-cell response to antigen challenge in vivo. Immunology and Cell Biology, 94 (3), 306-311. doi: 10.1038/icb.2015.82

Lethal giant larvae-1 deficiency enhances the CD8+ effector T-cell response to antigen challenge in vivo

2016

Journal Article

Complementarity and redundancy of IL-22-producing innate lymphoid cells

Rankin, Lucille C., Girard-Madoux, Mathilde J. H., Seillet, Cyril, Mielke, Lisa A., Kerdiles, Yann, Fenis, Aurore, Wieduwild, Elisabeth, Putoczki, Tracy, Mondot, Stanislas, Lantz, Olivier, Demon, Dieter, Papenfuss, Anthony T., Smyth, Gordon K., Lamkanfi, Mohamed, Carotta, Sebastian, Renauld, Jean-Christophe, Shi, Wei, Carpentier, Sabrina, Soos, Tim, Arendt, Christopher, Ugolini, Sophie, Huntington, Nicholas D, Belz, Gabrielle T. and Vivier, Eric (2016). Complementarity and redundancy of IL-22-producing innate lymphoid cells. Nature Immunology, 17 (2), 179-186. doi: 10.1038/ni.3332

Complementarity and redundancy of IL-22-producing innate lymphoid cells

2016

Journal Article

Innate lymphoid cells: Parallel checkpoints and coordinate interactions with T cells

Huntington, Nicholas D, Carpentier, Sabrina, Vivier, Eric and Belz, Gabrielle T (2016). Innate lymphoid cells: Parallel checkpoints and coordinate interactions with T cells. Current Opinion in Immunology, 38, 86-93. doi: 10.1016/j.coi.2015.11.008

Innate lymphoid cells: Parallel checkpoints and coordinate interactions with T cells

2016

Journal Article

Development, homeostasis, and heterogeneity of NK cells and ILC1

Seillet, Cyril, Belz, Gabrielle T. and Huntington, Nicholas D. (2016). Development, homeostasis, and heterogeneity of NK cells and ILC1. Current Topics in Microbiology and Immunology, 395, 37-61. doi: 10.1007/82_2015_474

Development, homeostasis, and heterogeneity of NK cells and ILC1

2016

Journal Article

The Helix-Loop-Helix Protein ID2 Governs NK Cell Fate by Tuning Their Sensitivity to Interleukin-15

Delconte, Rebecca B., Shi, Wei, Sathe, Priyanka, Ushiki, Takashi, Seillet, Cyril, Minnich, Martina, Kolesnik, Tatiana B., Rankin, Lucille C., Mielke, Lisa A., Zhang, Jian-Guo, Busslinger, Meinrad, Smyth, Mark J., Hutchinson, Dana S., Nutt, Stephen L., Nicholson, Sandra E., Alexander, Warren S., Corcoran, Lynn M., Vivier, Eric, Belz, Gabrielle, Carotta, Sebastian and Huntington, Nicholas D. (2016). The Helix-Loop-Helix Protein ID2 Governs NK Cell Fate by Tuning Their Sensitivity to Interleukin-15. Immunity, 44 (1), 103-115. doi: 10.1016/j.immuni.2015.12.007

The Helix-Loop-Helix Protein ID2 Governs NK Cell Fate by Tuning Their Sensitivity to Interleukin-15

2016

Book Chapter

Innate lymphoid cells type 3

Belz, Gabrielle T., Rankin, Lucille C., Carotta, Sebastian, Romagnani, Chiara and Huntington, Nicholas D. (2016). Innate lymphoid cells type 3. Encyclopedia of Immunobiology. (pp. 156-168) edited by Michael J.H. Ratcliffe. Cambridge, MA, United States: Academic Press. doi: 10.1016/B978-0-12-374279-7.04004-2

Innate lymphoid cells type 3

2016

Journal Article

Differentiation and diversity of subsets in group 1 innate lymphoid cells

Seillet, Cyril and Belz, Gabrielle T. (2016). Differentiation and diversity of subsets in group 1 innate lymphoid cells. International Immunology, 28 (1), 3-11. doi: 10.1093/intimm/dxv051

Differentiation and diversity of subsets in group 1 innate lymphoid cells

2015

Journal Article

CCR2 defines in vivo development and homing of IL-23-driven GM-CSF-producing Th17 cells

Kara, Ervin E., McKenzie, Duncan R., Bastow, Cameron R., Gregor, Carly E., Fenix, Kevin A., Ogunniyi, Abiodim D., Paton, James C., Mack, Matthias, Pombal, Diana R., Seillet, Cyrill, Dubois, Benedocte, Liston, Adrian, Macdonald, Kelli P. A., Belz, Gabrielle T., Smyth, Mark J., Hill, Geoffrey R., Comerford, Iain and McColl, Shaun R. (2015). CCR2 defines in vivo development and homing of IL-23-driven GM-CSF-producing Th17 cells. Nature Communications, 6 (1) 8644, 8644. doi: 10.1038/ncomms9644

CCR2 defines in vivo development and homing of IL-23-driven GM-CSF-producing Th17 cells

2015

Journal Article

A role for the mitochondrial protein Mrpl44 in maintaining OXPHOS capacity

Yeo, Janet H.C., Skinner, Jarrod P.J., Bird, Matthew J., Formosa, Luke E., Zhang, Jian- Guo, Kluck, Ruth M., Belz, Gabrielle T. and Chong, Mark M.W. (2015). A role for the mitochondrial protein Mrpl44 in maintaining OXPHOS capacity. PLoS One, 10 (7) e0134326. doi: 10.1371/journal.pone.0134326

A role for the mitochondrial protein Mrpl44 in maintaining OXPHOS capacity

2015

Journal Article

Donor colonic CD103(+) dendritic cells determine the severity of acute graft-versus-host disease

Koyama, Motoko, Cheong, Melody, Markey, Kate A., Gartlan, Kate H., Kuns, Rachel D., Locke, Kelly R., Lineburg, Katie E., Teal, Bianca E., Leveque-El Mouttie, Lucie, Bunting, Mark D., Vuckovic, Slavica, Zhang, Ping, Teng, Michele W. L., Varelias, Antiopi, Tey, Siok-Keen, Wockner, Leesa F., Engwerda, Christian R., Smyth, Mark J., Belz, Gabrielle T., McColl, Shaun R., MacDonald, Kelli P. A. and Hill, Geoffrey R. (2015). Donor colonic CD103(+) dendritic cells determine the severity of acute graft-versus-host disease. Journal of Experimental Medicine, 212 (8), 1303-1321. doi: 10.1084/jem.20150329

Donor colonic CD103(+) dendritic cells determine the severity of acute graft-versus-host disease

2015

Journal Article

Confocal laser endomicroscopy to monitor the colonic mucosa of mice

Mielke, Lisa, Preaudet, Adele, Belz, Gabrielle and Putoczki, Tracy (2015). Confocal laser endomicroscopy to monitor the colonic mucosa of mice. Journal of Immunological Methods, 421, 81-88. doi: 10.1016/j.jim.2015.04.012

Confocal laser endomicroscopy to monitor the colonic mucosa of mice

2015

Journal Article

CD3 bright signals on γδ T cells identify IL-17A-producing Vγ6Vδ1+T cells

Paget, C., Chow, M. T., Gherardin, N. A., Beavis, P. A., Uldrich, A. P., Duret, H., Hassane, M., Souza-Fonseca-Guimaraes, F., Mogilenko, D. A., Staumont-Salle, D., Escalante, N. K., Hill, G. R., Neeson, P., Ritchie, D. S., Dombrowicz, D., Mallevaey, T., Trottein, F., Belz, G. T., Godfrey, D. I. and Smyth, M. J. (2015). CD3 bright signals on γδ T cells identify IL-17A-producing Vγ6Vδ1+T cells. Immunology and Cell Biology, 93 (2), 198-212. doi: 10.1038/icb.2014.94

CD3 bright signals on γδ T cells identify IL-17A-producing Vγ6Vδ1+T cells

Funding

Current funding

  • 2025 - 2029
    Unravelling immune signalling networks that protect vertebrates from attack
    ARC Australian Laureate Fellowships
    Open grant
  • 2024 - 2028
    METASPATIAL Study: Metabolic Spatial Analysis of Lung Cancer Study
    NHMRC MRFF EMCR - Early to Mid-Career Researchers
    Open grant
  • 2024 - 2026
    From Pixels to Prognosis: Harnessing single-cell spatial analysis to predict and improve immunotherapy response in lung cancer
    Cure Cancer Early Career Research Grants
    Open grant
  • 2024 - 2026
    Preclinical refinement of a UQ-Moderna vaccine developed to prevent StrepA infection
    NHMRC Development Grant
    Open grant
  • 2024 - 2025
    Screening experimental adjuvants in non-human primates for improved Group A Streptococcus (GAS) vaccine efficacy
    The University of Queensland in America, Inc
    Open grant
  • 2023 - 2026
    Regulation of lung immune-epithelial networks sensing environmental change
    ARC Discovery Projects
    Open grant
  • 2023 - 2028
    Building the next mRNA vaccines and therapies
    MRFF - National Critical Infrastructure Initiative
    Open grant
  • 2023 - 2026
    Personalising Innate-immunotherapy for Superior Treatment Outcomes with Large anticancer applicability (PISTOL)
    NHMRC MRFF EMCR - Early to Mid-Career Researchers
    Open grant
  • 2022 - 2026
    Harnessing immune cell programs to drive immune protection
    NHMRC Investigator Grants
    Open grant

Past funding

  • 2022 - 2024
    Determining Causative Mechanisms of Hidradenitis Suppurativa (TRI LINC grant led by MSHHS)
    Metro South Hospital and Health Service
    Open grant
  • 2022 - 2024
    LUNG PREDICT Study
    Cancer Australia
    Open grant
  • 2022
    Generating neuroprotective IgA through microbiome-epithelial interactions
    MS Research Australia Project Grant
    Open grant
  • 2022 - 2024
    Type 2 innate lymphoid cells orchestrate anti-melanoma responses.
    Cancer Council NSW Project Grant
    Open grant
  • 2021 - 2022
    Cutaneous squamous cell carcinoma and tumour MICroenvironment Multiplex Spatial Profiling - cMIC STUDY (PA Research Foundation Award administered by MSHHS)
    Metro South Hospital and Health Service
    Open grant
  • 2021 - 2023
    Coordinating neuroimmune sensory networks in health and disease
    NHMRC IDEAS Grants
    Open grant
  • 2020 - 2023
    New guardians of the mucosa: Molecular characterisation of M cell biology (ARC Discovery Project administered by UTS)
    University of Technology Sydney
    Open grant
  • 2020 - 2022
    Delineating immune circuits for innate and adaptive immune protection
    NHMRC Research Fellowship
    Open grant
  • 2019 - 2023
    The recirculation of myeloid dendritic cells
    ARC Discovery Projects
    Open grant
  • 2019 - 2021
    Understanding the circadian regulation of the innate lymphoid cells (NHMRC Project Grant administered by WEHI)
    Walter & Eliza Hall Institute of Medical Research (WEHI)
    Open grant

Supervision

Availability

Professor Gabrielle Belz is:
Available for supervision

Before you email them, read our advice on how to contact a supervisor.

Available projects

  • Understanding mucosal immunity

    The picture of the network governing the mucosal immunity and how the different immune populations interplay is only just emerging, but it is already opening a whole new array of exciting possibilities for immune regulation and immunotherapeutic strategies. Our current projects aim to provide a new dimension to this emerging field in understanding how mucosal epithelial cells interact with immune cells to drive mucosal immunosurveillance, homeostasis and immunity. We have developed a number of new tools to dissect this epithelial immune network and understand its regulation in immunity.

  • Delineating long-term protective immunity to pathogen infection

    Our work aims to understand how the immune system responds to infections including viruses, bacteria and parasites. We endeavour to elucidate how different types of immune cells develop, and what factors influences their decision to become one type of immune cell or another. Understanding how the body deals with pathogens will give clues about how to enhance protective immunity. Our goal is to discover new therapies that boost our immune system to protect against infection.

    Our research focuses on:

    • Elucidating the mechanisms responsible for the generation of protective immunity in response to lung and gastrointestinal pathogens including influenza, herpesvirus and intestinal bacterial infections
    • How protective immunity breaks down in chronic overwhelming infections
    • Identifying factors that can promote host immune responses and potent long-lived protective immunological memory

  • Understanding mucosal immunity

    The picture of the network governing the mucosal immunity and how the different immune populations interplay is only just emerging, but it is already opening a whole new array of exciting possibilities for immune regulation and immunotherapeutic strategies. Our current projects aim to provide a new dimension to this emerging field in understanding how mucosal epithelial cells interact with immune cells to drive mucosal immunosurveillance, homeostasis and immunity. We have developed a number of new tools to dissect this epithelial immune network and understand its regulation in immunity.

  • Delineating long-term protective immunity to pathogen infection

    Our work aims to understand how the immune system responds to infections including viruses, bacteria and parasites. We endeavour to elucidate how different types of immune cells develop, and what factors influences their decision to become one type of immune cell or another. Understanding how the body deals with pathogens will give clues about how to enhance protective immunity. Our goal is to discover new therapies that boost our immune system to protect against infection.

    Our research focuses on:

    • Elucidating the mechanisms responsible for the generation of protective immunity in response to lung and gastrointestinal pathogens including influenza, herpesvirus and intestinal bacterial infections
    • How protective immunity breaks down in chronic overwhelming infections
    • Identifying factors that can promote host immune responses and potent long-lived protective immunological memory

  • Unravelling immune signalling networks in mucosal immunity

    Mucosal surfaces are critical interfaces where host-environment interactions occur, and the interplay between epithelial cells and immune components is essential for balancing tolerance and immunity. Disruptions to mucosal barrier integrity have profound consequences, contributing to the onset and progression of numerous diseases. Moreover, mucosal surfaces are key entry points for pathogens, including emerging viral threats, making a robust barrier indispensable for preventing infection. Despite the importance of this barrier, our understanding of how it is regulated and integrates signals from the microbiome to the immune cells is poorly understood.

    This exciting opportunity aims to unravel the intricate interactions between immune cells and epithelial tissues, with a focus on understanding their roles in maintaining barrier integrity and immune homeostasis in mucosal environments such as the gut, lungs, and skin. This project will investigate how epithelial cells communicate with innate and adaptive immune cells to modulate responses to microbial, dietary, and environmental stimuli.

    Utilizing cutting-edge approaches including advanced imaging, organoid co-culture systems, multiomics, and animal models, the candidate will uncover molecular mechanisms that underpin immune-epithelial cross-talk. The findings will unravel new knowledge that sets the foundation for the development of new strategies for diseases such as inflammatory bowel disease, asthma, and other epithelial barrier disorders.

    The Belz Laboratory

    The successful candidate will join a dynamic and interdisciplinary research team in a supportive academic environment. Our team is composed of highly collaborative passionate post-doctoral scientists, research assistants and PhD students with diverse backgrounds. We have expertise in state-of the art imaging, multi-dimensional flow cytometry and mucosal immunology. We provide a unique, collaborative environment and opportunity to develop diverse skill-sets and make impactful discoveries.

    Frazer Institute at the University of Queensland

    The Frazer Institute at the University of Queensland offers a dynamic and collaborative research environment dedicated to advancing biomedical innovation. Situated in Brisbane, a vibrant and rapidly growing hub for science and technology, the Institute provides access to world-class facilities and resources in a stunning subtropical setting.

    As a leading research centre, the Frazer Institute fosters interdisciplinary collaboration, bringing together experts in immunology, molecular biology, and translational medicine. Its strategic partnerships with hospitals, biotech industries, and global research networks enable researchers to translate discoveries into real-world applications.

    The Institute is equipped with state-of-the-art technologies, including single-cell genomics, high-resolution imaging, organoid platforms, and advanced proteomics. These cutting-edge tools empower researchers to explore complex biological questions with unprecedented precision.

    With its emphasis on mentorship, innovation, and impact-driven research, the Frazer Institute offers exceptional opportunities for scientists aiming to contribute to transformative discoveries in health and medicine.

    The Frazer Institute is committed to diversity and equal opportunity and the development of emerging researchers at the highest level.

Supervision history

Current supervision

Completed supervision

Media

Enquiries

For media enquiries about Professor Gabrielle Belz's areas of expertise, story ideas and help finding experts, contact our Media team:

communications@uq.edu.au